Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
03/2002
03/20/2002EP1187915A2 Compounds for therapy and diagnosis of lung cancer and methods for their use
03/20/2002EP1187914A1 A structured peptide scaffold for displaying turn libraries on phages
03/20/2002EP1187912A1 In vivo insect model system for type-2 diabetes
03/20/2002EP1187908A1 42 human secreted proteins
03/20/2002EP1187845A2 Tumor suppressor molecules and methods of use
03/20/2002EP1187843A1 Angiogenic proteins and uses thereof
03/20/2002EP1187678A1 Device for implementing an analysis pack, analysis pack and method using same
03/20/2002EP1187670A1 CALIBRATION OF AN NOx SENSOR AND REGULATION OF AN UPSTREAM NOx STORAGE CATALYST
03/20/2002EP1187630A1 Rapid immunoassay to detect antibodies in saliva to disease-related microorganisms antigens
03/20/2002EP1187626A1 Methods for producing 5'-nucleic acid-protein conjugates
03/20/2002EP1187591A2 Ibd-associated microbial antigens and methods of using same
03/20/2002EP1187533A1 Method and apparatus for removing fat from meat cuts
03/20/2002EP1166077A4 Improved biosensor device and method of manufacturing same
03/20/2002EP1139101A9 Immunoassay for c-reactive protein
03/20/2002EP1131629A4 Reagent composition and method for identification of reticulated cells
03/20/2002EP1124721A4 Systems and methods for modifying ice adhesion strength
03/20/2002EP1068506A4 Apparatus and method for testing lubricity
03/20/2002EP1021166A4 Liposome reagents for immunoassays
03/20/2002EP1012597A4 Methods for the detection of nitric oxide in fluid media
03/20/2002EP0963443A4 Releasable nonvolatile mass-label molecules
03/20/2002EP0946818B1 Method and device for process control during bleaching of fibrous materials
03/20/2002EP0915851B1 Dibenzodihydropyridinecarboxylic esters and their use in chemiluminescent assay methods
03/20/2002EP0904529B1 Ndir apparatus and method for measuring isotopic ratios in gaseous samples
03/20/2002EP0901634B1 A system for determining at least one parameter of at least one sample of a physiological liquid and a cassette
03/20/2002EP0853763B1 Device for determining the dissolution time of medicaments in pressed form, like tablets, pills or capsules
03/20/2002EP0832433B1 Stabilized standards and calibrators
03/20/2002EP0801689A4 Method of screening for genetic predisposition to anticholinesterase therapy
03/20/2002EP0762828A4 Method and reagent system for the improved determination of white blood cell subpopulations
03/20/2002EP0725682B1 Microfabricated, flowthrough porous apparatus
03/20/2002EP0628077B1 Humanised antibodies directed against a33 antigen
03/20/2002EP0589961B1 Assay systems for neurotrophin activity
03/20/2002EP0418316B1 Platelet-specific chimeric immunoglobulin
03/20/2002CN2482692Y Mechanical scanning device
03/20/2002CN1341213A Process for screening compound having affinity for vitamin D receptor
03/20/2002CN1341212A Isolating cytoplasmic fraction without impairing viability of oocytes and embryonic cells
03/20/2002CN1341210A Disposable test strips with integrated reagent/blood separation layer
03/20/2002CN1341165A Electrolytic copper foil and method for inspecting physical property thereof, and copper clad laminate using electrolytic copper foil
03/20/2002CN1341151A Herbicide target gene and methods
03/20/2002CN1341123A Novel G protein-coupled receptor protein and DNA thereof
03/20/2002CN1341120A 骨刺激因子 Bone stimulator
03/20/2002CN1341118A Mitochondrial DNA damage as a predictor of coronary atherosclerotic heart disease
03/20/2002CN1341004A Polarized light scattering spectroscopy of tissue
03/20/2002CN1340712A Reagent kit for enzyme-linked immunoassay of rubella, macrocell and monospermous viruses and Toxoplasma antibody
03/20/2002CN1340711A Preparing process and application of detection probe
03/20/2002CN1340710A Application of ordinary-temp vitrification technique in preparing immunochromatographic test strip stable at ordinary temp
03/20/2002CN1340709A Container for preservation of biological fluid for analysis
03/20/2002CN1340708A Quality control method and its equipment for automatic analysis of biological substance
03/20/2002CN1340707A Multi-level test method for HCG value of urine
03/20/2002CN1340706A Reagent kit and method for testing epidemic disease pathogen of prawn
03/20/2002CN1340704A Application of vitrification technique in preparing enzyme-electrode test strip of electrochemical sensor for testing blood sugar
03/20/2002CN1340548A Decontamination and application of human recombined cartilage oligo-substrate protein
03/20/2002CN1340413A 树脂再生系统 Resin regeneration system
03/20/2002CN1340382A Device for tank for cooling contained liquid sample to be analyzed, especially for cooling contained petroleum product
03/20/2002CN1081333C Process for measuring amount of endotoxin or (1-3)-beta-D-glucan in sample and its reagent
03/20/2002CN1081332C Preserving method for liquid diagnostic medicament and air-tight container
03/20/2002CN1081327C Device for contactless continuous measuring core pore structure
03/19/2002USRE37596 Hybridoma cell line which produces the monoclonal antibody bw sclc-1 having the deposit number ecacc no. 90022110.
03/19/2002US6359284 Scanner type fluorescence detection apparatus
03/19/2002US6359190 Garment
03/19/2002US6359127 Oligonucleotide for use in treatment of cancer and nervous system disorders
03/19/2002US6359126 Antibodies to αvβ3 integrin
03/19/2002US6359125 Process for preparing peptide nucleic acid probe using polymeric photoacid generator
03/19/2002US6359116 Compounds
03/19/2002US6359115 Human receptor tyrosine kinase, KDR
03/19/2002US6358996 Stable isotope labeling of paclitaxel
03/19/2002US6358923 Preventing and diagnosing blood, genetic, and nervous system disorders associated with decreased genetic expression
03/19/2002US6358915 Administering uteroglobin as anticarcinogenic or antitumor agent to treat breast, lung or prostate cancer
03/19/2002US6358754 (Bio)chemical reagent solid phases, process for their production and their applications
03/19/2002US6358753 Generating preferential microarray structure; obtain antibody, incubate with microarray, adjust ionic concentration, recover microarray
03/19/2002US6358752 Liposome-enhanced test device and method
03/19/2002US6358751 Involvement of autoantigens in cardiac graft rejection
03/19/2002US6358750 Spiro[pyrrolidine-2,3′-oxindole] compounds and method of use
03/19/2002US6358746 Fluorescent compounds for use in industrial water systems
03/19/2002US6358727 Nucleotide sequences coding binding protein for use in treatment and prevention of infections
03/19/2002US6358710 Humanized antibodies that bind to the antigen bound by antibody NR-LU-13
03/19/2002US6358708 Nucleotide sequence coding segment of enzymatic polypeptide; for use in treatment and prevention of fungal infections; fungicides
03/19/2002US6358706 Nucleotide sequences coding membrane protein; for use in treatment of epilepsy, schizophrenia, depression, sleep, stress, muscle, endocrine, respiratory, fertility, contraceptive, cardiovascular disorders and atherosclerosis
03/19/2002US6358704 M protein
03/19/2002US6358700 Using fluorescent dye
03/19/2002US6358698 Determing antipsychotic activity of compounds by exposing a serotonin receptor having wild type activity with a test compound; then measure basal activity of the receptor; decreased activity indicates antipsychotic drug compound
03/19/2002US6358695 Determining compounds that activate or inhibit a g-protein receptor by exposing cells expressing the polypeptide on the surface with a test compound to allow binding and detect a signal in response to binding of agent to the polypeptide
03/19/2002US6358694 Culturing prostaglandin receptor expressing cells in the presence of a test compound; measure the modulating affects of the compound that interacts with the recombinant receptor and compare the affects with a control host cell
03/19/2002US6358693 AMPA-binding human gluR4 receptor methods
03/19/2002US6358692 A multi-dimensional method for sreening binding affinities of ligands by mixing solutions of heterogenous ligands with targets of interest to form complexes that will then be separated by size exclusion chromatography
03/19/2002US6358689 Detection of markers in nascent proteins
03/19/2002US6358688 Immortalized human middle ear epithelial cell lines
03/19/2002US6358684 Hybridizing nucleic acid sequence with fluorescently labeled oligonucleotide primer in presence of deoxynucleoside triphosphates, dideoxynucleoside triphosphate and dna polymerase, fluorescently measuring mixture formed to sequence
03/19/2002US6358679 Methods for external controls for nucleic acid amplification
03/19/2002US6358613 Silicon substrate with layers of vinyl or alkyl groups bonded to silicon surface
03/19/2002US6358510 ICAM-1 derivatives with altered ability to bind LFA-1
03/19/2002US6358408 Apparatus for the enhancement of water quality in a subterranean pressurized water distribution system
03/19/2002US6358384 Electrochemical sensor for detecting a predetermined gas
03/19/2002US6357536 Method and apparatus for measuring fluid density and determining hole cleaning problems
03/19/2002US6357282 Tennis ball tester
03/19/2002CA2180365C A method and apparatus for controlling the feed of water treatment chemicals using a voltammetric sensor
03/19/2002CA2136330C Technetium-99m labeled peptides for thrombus imaging
03/15/2002CA2357279A1 Composition for density gradient cell separation
03/15/2002CA2357074A1 Novel bcl-2 related proline rich protein (bpr)
03/14/2002WO2002021428A1 Reference database
03/14/2002WO2002021418A2 Method and system for identifying commercially distributed organisms